Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection - 29/01/20
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 9 |
| Iconografia | 1 |
| Video | 0 |
| Altro | 0 |
Highlights |
• | Serum ceruloplasmin levels were positively correlated with hepatic steatosis degree in Chronic hepatitis B patients. |
• | Serum ceruloplasmin has a potential diagnostic value in predicting the grade of hepatic steatosis in Chronic hepatitis B patients. |
• | Two novel models with the combination of serum ceruloplasmin values can predict hepatic steatosis or grade 2-3 hepatic steatosis in Chronic hepatitis B patients with high degrees of accuracy. |
• | Our novel model (HSCHB-1) was superior to hepatic steatosis index、fatty liver disease index and steatosis index of patients with hepatitis B virus infection in predicting hepatic steatosis in Chronic hepatitis B patients. |
Summary |
Aims |
To evaluate the significance of serum ceruloplasmin (CP) to diagnosis hepatic steatosis (HS) in Chronic hepatitis B (CHB) patients.
Methods |
A total of 360 CHB patients with HS (n = 136) or without HS (n = 224) were included. Relationships between CP and HS degrees were analyzed by Spearman rank correlation. HS-predictive models including CP were constructed using multivariate logistic regression analysis and compared to other HS predicting indexes.
Results |
Serum CP were significantly higher in CHB patients with HS than in patients without HS (P < 0.001) and were positively correlated with HS degree (r = 0.487, P < 0.001). The area under the receiver-operating characteristic curves (AUCs) of using CP to predict HS (S ≥ 1), moderate and severe steatosis (S ≥ 2) and severe steatosis (S = 3) were 0.758, 0.794 and 0.883, respectively. Multivariate analysis showed that CP, age, high density lipoprotein (HDL) and hemoglobin were independent predictors of HS, and CP, body mass index and HDL were independent predictors of moderate and severe HS. Two novel indexes for predicting HS of CHB patients were generated. The AUC of HSCHB-1 (for S ≥ 1) and HSCHB-2 (for S ≥ 2) were 0.881 and 0.916 in the training group, and 0.865 and 0.841 in the validation group, respectively. HSCHB-1 was superior to HS index (P < 0.001), fatty liver disease index (P = 0.0043) and steatosis index of patients with hepatitis B virus infection (P = 0.0029) in predicting HS in CHB patients.
Conclusions |
HS of CHB patients was positively associated with serum CP. HSCHB-1 and HSCHB-2 with inclusion of CP are two novel models for predicting HS in CHB patients.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : ALT, AST, ApoA, AUC, BMI, CHB, CHE, CI, CP, FLD, FPG, GGT, TBIL, HBeAg, HBV, HCC, HDL, HGB, HBsAg, HS, HSI, LDL, NAFLD, NASH, MRS, NPV, OR, PLT, PPV, PT, ROC, SD, SIHBV, SUA, TCHO, TE, TG, ULN, VLDL, Wald χ2, WBC, WD
Keywords : Ceruloplasmin, Hepatic steatosis, Chronic hepatitis B infection, Receiver-operating characteristic, Area under the curve
Mappa
Vol 44 - N° 1
P. 57-65 - febbraio 2020 Ritorno al numero
Articolo precedente
- HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population
- Fabrizio Fabrizi, Roberta Cerutti, Luca Nardelli, Federica Tripodi, Piergiorgio Messa
- B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia
- Lorenza Matarazzo, Teresa Di Chio, Silvia Nastasio, Alberto Tommasini, Alessando Ventura, Giuseppe Maggiore
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?